-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
CML, Diseases, Technology and Procedures, Myeloid Malignancies, WGS
Monday, December 7, 2020: 7:00 AM-3:30 PM

Kristina Loy*, Melanie Zenger*, Manja Meggendorfer, PhD, Stephan Hutter, PhD*, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD and Constance Baer, PhD

MLL Munich Leukemia Laboratory, Munich, Germany

*signifies non-member of ASH